CoChat

Comparison of Continuous Positive Airway Pressure and Valsartan in Hypertensive Patients with Sleep Apnea

Pépin, Jean-Louis, Tamisier, Renaud, Barone-Rochette, Gilles, Launois, Sandrine H., Lévy, Patrick, Baguet, Jean-Philippe · 2010 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Rationale: Randomized controlled trials (RCTs) have shown that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) reduces blood pressure (BP). CPAP treatment has never been compared with antihypertensive medications in an RCT. Objectives: To assess the respective efficacy of CPAP and valsartan in reducing BP in hypertensive patients with OSA never treated for either condition. Methods: In this 8-week randomized controlled crossover trial, 23 hypertensive patients (office systolic BP/diastolic BP: 155 ± 14/102 ± 11 mm Hg) with OSA (age, 57 ± 8 yr; body mass index, 28 ± 5 kg/m2; apnea–hypopnea index, 29 ± 18/h) were randomized first to either CPAP or valsartan (160 mg). The second 8-week period consisted of the alternative treatment (crossover) after a 4-week washout period. Measurements and Main Results: Office BP and 24-hour BP were measured before and at the end of the two active treatment periods. Twenty-four–hour mean BP was the primary outcome variable. There was an overall significant difference in 24-hour mean BP between treatments: the change in 24-hour mean BP was −2.1 ± 4.9 mm Hg (P < 0.01) with CPAP, and −9.1 ± 7.2 mm Hg with valsartan (P < 0.001), with a difference of −7.0 mm Hg (95% confidence interval, −10.9 to −3.1 mm Hg; P < 0.001). The difference was significant not only during daytime but also during nighttime: the change in nighttime mean BP with CPAP was −1.3 ± 4.6 mm Hg (not significant), and −7.4 ± 8.4 mm Hg with valsartan (P < 0.001), with a difference of −6.1 mm Hg (P < 0.05) (95% confidence interval, −10.8 to −1.4 mm Hg). Conclusions: In an RCT, although the BP decrease was significant with CPAP treatment, valsartan induced a fourfold higher decrease in mean 24-hour BP than CPAP in untreated hypertensive patients with OSA. Clinical trial registered with www.clinicaltrials.gov (NCT00409487).

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.200912-1803oc

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 27

  1. 2000, N Engl J Med, 1378
  2. 1999, Hypertension, 309
  3. 2009, J Appl Physiol, 17
  4. 2007, Arch Intern Med, 757
  5. 2007, Hypertension, 417
  6. 2007, Lung, 67
  7. 2009, J Hum Hypertens, 431
  8. 2000, Respir Physiol, 189
  9. 2000, Am J Respir Crit Care Med, 1423
  10. 2008, Proc Am Thorac Soc, 207
  11. 2004, Drugs, 2537
  12. 2005, J Hypertens, 2313
  13. 2003, J Hypertens, 821
  14. 2009, Sleep Med Rev, 323
  15. 2010, Am J Respir Crit Care Med, 718
  16. 2003, Am J Hypertens, 274
  17. 2009, Eur Respir J, 1390
  18. 2000, J Appl Physiol, 493
  19. 2006, Respir Physiol Neurobiol, 278
  20. 2009, Arch Intern Med, 1619
  21. 2008, Rev Cardiovasc Med, 159
  22. 2009, Diabetes Care, 1017
  23. 2006, Arch Intern Med, 1716
  24. 2009, PLoS Med, e1000132
  25. 2006, Eur Respir J, 1229
  26. 2008, Hypertension, 55
  27. 2009, Eur Respir J, 694

Cited by

See all 242

Metadata

Authors
Pépin, J.-L., Tamisier, R., Barone-Rochette, G., Launois, S. H., Lévy, P., & Baguet, J.-P.
Affiliations
  • Inserm (FR)
  • Department of Cardiology, Grenoble University Hospital, Grenoble, France; and
  • Rehabilitation and Physiology Department and
  • Centre Hospitalier Universitaire de Grenoble (FR)
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2010-10-01
Volume
182
Issue
7
Pages
954-960
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2143702903
Cited by
232
References
28
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 11 · 2021: 14 · 2020: 8 · 2019: 14 · 2018: 25 · 2017: 14 · 2016: 17 · 2015: 22 · 2014: 24 · 2013: 17 · 2012: 20
FWCI
12.26
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
continuous positive airway pressure, valsartan, obstructive sleep apnea, hypertension, blood pressure reduction, antihypertensive therapy, 24-hour ambulatory blood pressure, nocturnal blood pressure, crossover trial, treatment comparison, angiotensin receptor blockers, sleep-disordered breathing, cardiovascular risk reduction, body mass index, apnea-hypopnea index
MeSH terms
Valsartan, Female, Humans, Hypertension, Male, Middle Aged, Tetrazoles, Valine, Comorbidity, Cross-Over Studies, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Angiotensin II Type 1 Receptor Blockers, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of Continuous Positive Airway Pressure and Valsartan in Hypertensive Patients with Sleep Apnea. https://app.cochat.ai/papers/10.1164/rccm.200912-1803oc
The paper
Pépin, J.-L., Tamisier, R., Barone-Rochette, G., Launois, S. H., Lévy, P., & Baguet, J.-P. (2010). Comparison of Continuous Positive Airway Pressure and Valsartan in Hypertensive Patients with Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200912-1803oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.